RAS Mutation Identifies a Poor Prognostic Molecular Subtype of Therapy-Related Myeloid Neoplasm

Files

hdl_147791.pdf (249.23 KB)
  (Published version)

Date

2025

Authors

Kok, C.H.
Al-Kali, A.
Thomas, D.
He, R.
Kutyna, M.M.
Alkhateeb, H.B.
Lim, K.
Saliba, A.N.
Toop, C.
Matin, A.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

Blood advances, 2025; 9(15):3814-3818

Statement of Responsibility

Chung Hoow Kok, Aref Al-Kali, Daniel Thomas, Rong He, Monika M. Kutyna, Hassan Alkhateeb, Kelly Lim, Antoine N. Saliba, Carla Toop, Aasiya Matin, Hamish Scott, Naseema Gangat, Anna Brown, Abhishek Mangaonkar, Christopher N. Hahn, Kebede Begna, Kevin Hung, Patricia Greipp, William J. Hogan, Mrinal Patnaik, Mithun Shah, and Devendra K. Hiwase

Conference Name

Abstract

Abstract not available.

School/Discipline

Dissertation Note

Provenance

Description

Research Letter

Access Status

Rights

© 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

License

Grant ID

Call number

Persistent link to this record